View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
In association with THREAD
  1. Sponsored
November 8, 2021updated 03 Jan 2022 9:15am

Best Practices to scale global hybrid decentralized studies

As the industry continues to shift to decentralized clinical trial (DCT) approaches, sponsors and CROs must now focus on how to make this change globally. This session will outline best practices learned over the past years in conducting global DCTs that should be considered to scale globally across complex regulatory landscapes.

Watch the video to learn:

  • How to identify and plan the initial studies for DCT approaches to scale
  • Understand how to evaluate country-specific regulatory requirements and feature specific limitations
  • Assess DCT providers for optimal capabilities related to integrations, technical helpdesk, device provisioning and multi-lingual support availability

Speaker

John Reites, CEO, THREAD

Free Webinar

THREAD: Best Practices to Scale Global Hybrid Decentralized Studies

Download and watch the webinar

 

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena